This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mühlberger, E.
Right arrow Articles by Becker, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mühlberger, E.
Right arrow Articles by Becker, S.

 Previous Article  |  Next Article 

Journal of Virology, March 1999, p. 2333-2342, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Comparison of the Transcription and Replication Strategies of Marburg Virus and Ebola Virus by Using Artificial Replication Systems

Elke Mühlberger,* Michael Weik, Viktor E. Volchkov, Hans-Dieter Klenk, and Stephan Becker*

Institut für Virologie der Philipps-Universität Marburg, 35037 Marburg, Germany

Received 5 September 1998/Accepted 16 November 1998

The members of the family Filoviridae, Marburg virus (MBGV) and Ebola virus (EBOV), are very similar in terms of morphology, genome organization, and protein composition. To compare the replication and transcription strategies of both viruses, an artificial replication system based on the vaccinia virus T7 expression system was established for EBOV. Specific transcription and replication of an artificial monocistronic minireplicon was demonstrated by reporter gene expression and detection of the transcribed and replicated RNA species. As it was shown previously for MBGV, three of the four EBOV nucleocapsid proteins, NP, VP35, and L, were essential and sufficient for replication. In contrast to MBGV, EBOV-specific transcription was dependent on the presence of the fourth nucleocapsid protein, VP30. When EBOV VP30 was replaced by MBGV VP30, EBOV-specific transcription was observed but with lower efficiency. Exchange of NP, VP35, and L between the two replication systems did not lead to detectable reporter gene expression. It was further observed that neither MBGV nor EBOV were able to replicate the heterologous minigenomes. A chimeric minigenome, however, containing the EBOV leader and the MBGV trailer was encapsidated, replicated, transcribed, and packaged by both viruses.

* Corresponding author. Mailing address: Institut für Virologie der Philipps-Universität Marburg, Robert-Koch-Str. 17, 35037 Marburg, Germany. Phone: 6421-285433. Fax: 6421-285482. E-mail (E.M.): muehlber{at}mailer.uni-marburg.de. E-mail (S.B.): becker{at}mailer.uni-marburg.de.

Journal of Virology, March 1999, p. 2333-2342, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Schumann, M., Gantke, T., Muhlberger, E. (2009). Ebola Virus VP35 Antagonizes PKR Activity through Its C-Terminal Interferon Inhibitory Domain. J. Virol. 83: 8993-8997 [Abstract] [Full Text]  
  • Kubota, T., Matsuoka, M., Chang, T.-H., Bray, M., Jones, S., Tashiro, M., Kato, A., Ozato, K. (2009). Ebolavirus VP35 Interacts with the Cytoplasmic Dynein Light Chain 8. J. Virol. 83: 6952-6956 [Abstract] [Full Text]  
  • Enterlein, S., Schmidt, K. M., Schumann, M., Conrad, D., Krahling, V., Olejnik, J., Muhlberger, E. (2009). The Marburg Virus 3' Noncoding Region Structurally and Functionally Differs from That of Ebola Virus. J. Virol. 83: 4508-4519 [Abstract] [Full Text]  
  • Halfmann, P., Ebihara, H., Marzi, A., Hatta, Y., Watanabe, S., Suresh, M., Neumann, G., Feldmann, H., Kawaoka, Y. (2009). Replication-Deficient Ebolavirus as a Vaccine Candidate. J. Virol. 83: 3810-3815 [Abstract] [Full Text]  
  • Prins, K. C., Cardenas, W. B., Basler, C. F. (2009). Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKK{varepsilon} and TBK-1. J. Virol. 83: 3069-3077 [Abstract] [Full Text]  
  • Martinez, M. J., Biedenkopf, N., Volchkova, V., Hartlieb, B., Alazard-Dany, N., Reynard, O., Becker, S., Volchkov, V. (2008). Role of Ebola Virus VP30 in Transcription Reinitiation. J. Virol. 82: 12569-12573 [Abstract] [Full Text]  
  • Hartman, A. L., Ling, L., Nichol, S. T., Hibberd, M. L. (2008). Whole-Genome Expression Profiling Reveals That Inhibition of Host Innate Immune Response Pathways by Ebola Virus Can Be Reversed by a Single Amino Acid Change in the VP35 Protein. J. Virol. 82: 5348-5358 [Abstract] [Full Text]  
  • Hartman, A. L., Bird, B. H., Towner, J. S., Antoniadou, Z.-A., Zaki, S. R., Nichol, S. T. (2008). Inhibition of IRF-3 Activation by VP35 Is Critical for the High Level of Virulence of Ebola Virus. J. Virol. 82: 2699-2704 [Abstract] [Full Text]  
  • Halfmann, P., Kim, J. H., Ebihara, H., Noda, T., Neumann, G., Feldmann, H., Kawaoka, Y. (2008). Generation of biologically contained Ebola viruses. Proc. Natl. Acad. Sci. USA 105: 1129-1133 [Abstract] [Full Text]  
  • John, S. P., Wang, T., Steffen, S., Longhi, S., Schmaljohn, C. S., Jonsson, C. B. (2007). Ebola Virus VP30 Is an RNA Binding Protein. J. Virol. 81: 8967-8976 [Abstract] [Full Text]  
  • Noda, T., Watanabe, S., Sagara, H., Kawaoka, Y. (2007). Mapping of the VP40-Binding Regions of the Nucleoprotein of Ebola Virus. J. Virol. 81: 3554-3562 [Abstract] [Full Text]  
  • Muller, S., Moller, P., Bick, M. J., Wurr, S., Becker, S., Gunther, S., Kummerer, B. M. (2007). Inhibition of Filovirus Replication by the Zinc Finger Antiviral Protein. J. Virol. 81: 2391-2400 [Abstract] [Full Text]  
  • Hartlieb, B., Muziol, T., Weissenhorn, W., Becker, S. (2007). Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. Proc. Natl. Acad. Sci. USA 104: 624-629 [Abstract] [Full Text]  
  • Feng, Z., Cerveny, M., Yan, Z., He, B. (2007). The VP35 Protein of Ebola Virus Inhibits the Antiviral Effect Mediated by Double-Stranded RNA-Dependent Protein Kinase PKR. J. Virol. 81: 182-192 [Abstract] [Full Text]  
  • Hoenen, T., Groseth, A., Kolesnikova, L., Theriault, S., Ebihara, H., Hartlieb, B., Bamberg, S., Feldmann, H., Stroher, U., Becker, S. (2006). Infection of Naive Target Cells with Virus-Like Particles: Implications for the Function of Ebola Virus VP24. J. Virol. 80: 7260-7264 [Abstract] [Full Text]  
  • Hartman, A. L., Dover, J. E., Towner, J. S., Nichol, S. T. (2006). Reverse Genetic Generation of Recombinant Zaire Ebola Viruses Containing Disrupted IRF-3 Inhibitory Domains Results in Attenuated Virus Growth In Vitro and Higher Levels of IRF-3 Activation without Inhibiting Viral Transcription or Replication.. J. Virol. 80: 6430-6440 [Abstract] [Full Text]  
  • Johnson, R. F., McCarthy, S. E., Godlewski, P. J., Harty, R. N. (2006). Ebola Virus VP35-VP40 Interaction Is Sufficient for Packaging 3E-5E Minigenome RNA into Virus-Like Particles.. J. Virol. 80: 5135-5144 [Abstract] [Full Text]  
  • Cardenas, W. B., Loo, Y.-M., Gale, M. Jr., Hartman, A. L., Kimberlin, C. R., Martinez-Sobrido, L., Saphire, E. O., Basler, C. F. (2006). Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling.. J. Virol. 80: 5168-5178 [Abstract] [Full Text]  
  • Watanabe, S., Noda, T., Kawaoka, Y. (2006). Functional mapping of the nucleoprotein of ebola virus.. J. Virol. 80: 3743-3751 [Abstract] [Full Text]  
  • Enterlein, S., Warfield, K. L., Swenson, D. L., Stein, D. A., Smith, J. L., Gamble, C. S., Kroeker, A. D., Iversen, P. L., Bavari, S., Muhlberger, E. (2006). VP35 Knockdown Inhibits Ebola Virus Amplification and Protects against Lethal Infection in Mice. Antimicrob. Agents Chemother. 50: 984-993 [Abstract] [Full Text]  
  • Enterlein, S., Volchkov, V., Weik, M., Kolesnikova, L., Volchkova, V., Klenk, H.-D., Muhlberger, E. (2006). Rescue of Recombinant Marburg Virus from cDNA Is Dependent on Nucleocapsid Protein VP30. J. Virol. 80: 1038-1043 [Abstract] [Full Text]  
  • Pham, Q. N., Biacchesi, S., Skiadopoulos, M. H., Murphy, B. R., Collins, P. L., Buchholz, U. J. (2005). Chimeric Recombinant Human Metapneumoviruses with the Nucleoprotein or Phosphoprotein Open Reading Frame Replaced by That of Avian Metapneumovirus Exhibit Improved Growth In Vitro and Attenuation In Vivo. J. Virol. 79: 15114-15122 [Abstract] [Full Text]  
  • Moller, P., Pariente, N., Klenk, H.-D., Becker, S. (2005). Homo-Oligomerization of Marburgvirus VP35 Is Essential for Its Function in Replication and Transcription. J. Virol. 79: 14876-14886 [Abstract] [Full Text]  
  • Neumann, G., Ebihara, H., Takada, A., Noda, T., Kobasa, D., Jasenosky, L. D., Watanabe, S., Kim, J. H., Feldmann, H., Kawaoka, Y. (2005). Ebola Virus VP40 Late Domains Are Not Essential for Viral Replication in Cell Culture. J. Virol. 79: 10300-10307 [Abstract] [Full Text]  
  • Weik, M., Enterlein, S., Schlenz, K., Muhlberger, E. (2005). The Ebola Virus Genomic Replication Promoter Is Bipartite and Follows the Rule of Six. J. Virol. 79: 10660-10671 [Abstract] [Full Text]  
  • Carter, J. R., Pager, C. T., Fowler, S. D., Dutch, R. E. (2005). Role of N-Linked Glycosylation of the Hendra Virus Fusion Protein. J. Virol. 79: 7922-7925 [Abstract] [Full Text]  
  • Buchholz, U. J., Biacchesi, S., Pham, Q. N., Tran, K. C., Yang, L., Luongo, C. L., Skiadopoulos, M. H., Murphy, B. R., Collins, P. L. (2005). Deletion of M2 Gene Open Reading Frames 1 and 2 of Human Metapneumovirus: Effects on RNA Synthesis, Attenuation, and Immunogenicity. J. Virol. 79: 6588-6597 [Abstract] [Full Text]  
  • Zhang, J., Yamada, O., Sakamoto, T., Yoshida, H., Araki, H., Shimotohno, K. (2005). Exploiting cis-Acting Replication Elements To Direct Hepatitis C Virus-Dependent Transgene Expression. J. Virol. 79: 5923-5932 [Abstract] [Full Text]  
  • Groseth, A., Feldmann, H., Theriault, S., Mehmetoglu, G., Flick, R. (2005). RNA Polymerase I-Driven Minigenome System for Ebola Viruses. J. Virol. 79: 4425-4433 [Abstract] [Full Text]  
  • Fowler, T., Bamberg, S., Moller, P., Klenk, H.-D., Meyer, T. F., Becker, S., Rudel, T. (2005). Inhibition of Marburg virus protein expression and viral release by RNA interference. J. Gen. Virol. 86: 1181-1188 [Abstract] [Full Text]  
  • Shaw, M. L., Garcia-Sastre, A., Palese, P., Basler, C. F. (2004). Nipah Virus V and W Proteins Have a Common STAT1-Binding Domain yet Inhibit STAT1 Activation from the Cytoplasmic and Nuclear Compartments, Respectively. J. Virol. 78: 5633-5641 [Abstract] [Full Text]  
  • Watanabe, S., Watanabe, T., Noda, T., Takada, A., Feldmann, H., Jasenosky, L. D., Kawaoka, Y. (2004). Production of Novel Ebola Virus-Like Particles from cDNAs: an Alternative to Ebola Virus Generation by Reverse Genetics. J. Virol. 78: 999-1005 [Abstract] [Full Text]  
  • Hartlieb, B., Modrof, J., Muhlberger, E., Klenk, H.-D., Becker, S. (2003). Oligomerization of Ebola Virus VP30 Is Essential for Viral Transcription and Can Be Inhibited by a Synthetic Peptide. J. Biol. Chem. 278: 41830-41836 [Abstract] [Full Text]  
  • Basler, C. F., Mikulasova, A., Martinez-Sobrido, L., Paragas, J., Muhlberger, E., Bray, M., Klenk, H.-D., Palese, P., Garcia-Sastre, A. (2003). The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3. J. Virol. 77: 7945-7956 [Abstract] [Full Text]  
  • Ikegami, T., Niikura, M., Saijo, M., Miranda, M. E., Calaor, A. B., Hernandez, M., Acosta, L. P., Manalo, D. L., Kurane, I., Yoshikawa, Y., Morikawa, S. (2003). Antigen Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Reston Ebola Virus Nucleoprotein. CVI 10: 552-557 [Abstract] [Full Text]  
  • Modrof, J., Becker, S., Muhlberger, E. (2003). Ebola Virus Transcription Activator VP30 Is a Zinc-Binding Protein. J. Virol. 77: 3334-3338 [Abstract] [Full Text]  
  • Park, M.-S., Shaw, M. L., Munoz-Jordan, J., Cros, J. F., Nakaya, T., Bouvier, N., Palese, P., Garcia-Sastre, A., Basler, C. F. (2002). Newcastle Disease Virus (NDV)-Based Assay Demonstrates Interferon-Antagonist Activity for the NDV V Protein and the Nipah Virus V, W, and C Proteins. J. Virol. 77: 1501-1511 [Abstract] [Full Text]  
  • Neumann, G., Whitt, M. A., Kawaoka, Y. (2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol. 83: 2635-2662 [Abstract] [Full Text]  
  • Modrof, J., Muhlberger, E., Klenk, H.-D., Becker, S. (2002). Phosphorylation of VP30 Impairs Ebola Virus Transcription. J. Biol. Chem. 277: 33099-33104 [Abstract] [Full Text]  
  • Weik, M., Modrof, J., Klenk, H.-D., Becker, S., Muhlberger, E. (2002). Ebola Virus VP30-Mediated Transcription Is Regulated by RNA Secondary Structure Formation. J. Virol. 76: 8532-8539 [Abstract] [Full Text]  
  • Leroy, E. M., Baize, S., Mavoungou, E., Apetrei, C. (2002). Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization. J. Gen. Virol. 83: 67-73 [Abstract] [Full Text]  
  • Neumann, G., Feldmann, H., Watanabe, S., Lukashevich, I., Kawaoka, Y. (2002). Reverse Genetics Demonstrates that Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Essential for Replication in Cell Culture. J. Virol. 76: 406-410 [Abstract] [Full Text]  
  • Feldmann, H., Volchkov, V. E., Volchkova, V. A., Stroher, U., Klenk, H.-D. (2001). Biosynthesis and role of filoviral glycoproteins. J. Gen. Virol. 82: 2839-2848 [Full Text]  
  • Marriott, A. C., Smith, J. M., Easton, A. J. (2001). Fidelity of Leader and Trailer Sequence Usage by the Respiratory Syncytial Virus and Avian Pneumovirus Replication Complexes. J. Virol. 75: 6265-6272 [Abstract] [Full Text]  
  • Jasenosky, L. D., Neumann, G., Lukashevich, I., Kawaoka, Y. (2001). Ebola Virus VP40-Induced Particle Formation and Association with the Lipid Bilayer. J. Virol. 75: 5205-5214 [Abstract] [Full Text]  
  • Harty, R. N., Brown, M. E., Wang, G., Huibregtse, J., Hayes, F. P. (2000). A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding. Proc. Natl. Acad. Sci. USA 10.1073/pnas.250277297v1 [Abstract] [Full Text]  
  • Volchkov, V. E., Volchkova, V. A., Mühlberger, E., Kolesnikova, L. V., Weik, M., Dolnik, O., Klenk, H.-D. (2001). Recovery of Infectious Ebola Virus from Complementary DNA: RNA Editing of the GP Gene and Viral Cytotoxicity. Science 291: 1965-1969 [Abstract] [Full Text]  
  • Basler, C. F., Wang, X., Muhlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., Garcia-Sastre, A., Palese, P. (2000). The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. USA 97: 12289-12294 [Abstract] [Full Text]  
  • Harty, R. N., Brown, M. E., Wang, G., Huibregtse, J., Hayes, F. P. (2000). A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding. Proc. Natl. Acad. Sci. USA 97: 13871-13876 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»